CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 72 filers reported holding CARDIFF ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $9,200,000 | -64.3% | 1,383,500 | -50.3% | 4.96% | -47.8% |
| Q1 2021 | $25,793,000 | -28.3% | 2,785,410 | +39.3% | 9.50% | +10.9% |
| Q4 2020 | $35,980,000 | +178.6% | 2,000,000 | +119.8% | 8.56% | +30.8% |
| Q3 2020 | $12,913,000 | +1386.0% | 910,000 | +424.9% | 6.55% | +1063.1% |
| Q2 2020 | $869,000 | – | 173,361 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
| Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
| Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
| Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
| Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
| Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
| Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |